Valuation: FONAR Corporation

Market Cap 125M 111M 104M 94.41M 178M 12.04B 180M 1.26B 487M 6.14B 470M 459M 19.74B P/E 2024
10.3x
P/E 2025 11.9x
Enterprise Value 108M 95.52M 89.12M 81.17M 153M 10.36B 155M 1.08B 419M 5.28B 404M 395M 16.97B EV / Sales 2024
0.9x
EV / Sales 2025 0.77x
Free-Float
76.43%
Yield 2024 *
-
Yield 2025 -
1 day-0.10%
6 months+2.69%
Current year+2.86%
Current year 18.3
Extreme 18.3
19.16
1 year 13.9
Extreme 13.9
19.16
3 years 12
Extreme 12
24.05
5 years 12
Extreme 12
24.05
10 years 11
Extreme 11
33.9
Manager TitleAgeSince
Chief Executive Officer 61 2016-02-10
Director of Finance/CFO 71 2022-08-31
Investor Relations Contact - 1978-05-31
Director TitleAgeSince
Chairman 61 2022-09-06
Date Insider Type Main position Quantity % Market Cap. Importance
6/3/26 Other

Chief Executive Officer

0 0%
6/3/26 Other

Chief Financial Officer

0 0%
6/3/26 Other

Director

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-0.10%-.--%+18.72%+29.42% 125M
+0.35%-2.99%+20.52%+31.06% 242B
+1.09%-4.65%-0.43%-0.76% 150B
-2.32%-3.27%-13.35%+36.07% 138B
-1.46%-3.01%-56.23%-17.35% 61.74B
-0.05%-1.32%+10.48%+22.34% 49.08B
+0.66%+0.19%-20.53%-20.70% 47.43B
+0.66%-2.90%+18.46%+52.17% 47.3B
-3.05%-2.62%-7.75%+36.49% 44.25B
-0.08%-1.92%+29.48%+60.45% 41.78B
Average -0.43%-2.16%-0.06%+22.92% 82.28B
Weighted average by Cap. -0.29%-3.27%+1.08%+21.95%

Financials

2024 2025
Net sales 103M 91.39M 85.27M 77.66M 147M 9.91B 148M 1.03B 401M 5.05B 386M 378M 16.24B 104M 92.69M 86.49M 78.77M 149M 10.05B 150M 1.05B 406M 5.12B 392M 383M 16.47B
Net income 10.57M 9.39M 8.76M 7.98M 15.06M 1.02B 15.19M 106M 41.15M 519M 39.67M 38.81M 1.67B 8.33M 7.4M 6.91M 6.29M 11.88M 803M 11.98M 83.7M 32.45M 409M 31.29M 30.61M 1.32B
Net Debt -14.8M -13.15M -12.27M -11.17M -21.1M -1.43B -21.28M -149M -57.63M -727M -55.57M -54.36M -2.34B -17.54M -15.58M -14.53M -13.24M -24.99M -1.69B -25.21M -176M -68.28M -861M -65.83M -64.41M -2.77B
Logo FONAR Corporation
FONAR Corporation is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance Imaging (MRI) for the detection and diagnosis of human diseases. The Company conducts its business in two segments: medical equipment and physician management and diagnostic services. Its medical equipment segment is conducted directly through the Company. Its physician management and diagnostic services segment is conducted through its subsidiary, Health Management Corporation of America (HMCA). Its signature product is the FONAR UPRIGHT Multi-Position MRI (STAND-UP MRI). HMCA provides management services, administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, hiring, maintenance service, and clerical and other non-medical personnel to medical providers engaged in diagnostic imaging. HMCA owns and operates six diagnostic imaging facilities in Florida.
Employees
535
  1. Stock Market
  2. Stocks
  3. FONR Stock